Week in Review

Week in Review

Week in Review

The Supreme Court allows Texas anti-abortion law to take effect, the Biden Administration directs DHS to support Afghan resettlement, and more…

Week in Review

Week in Review

FDA grants the Pfizer vaccine full approval, the Supreme Court requires the Biden Administration to enforce a Trump Administration immigration policy, and more…

Week in Review

Week in Review

A federal court upholds the CDC’s eviction moratorium, the Justice Department appeals a ruling that stopped a ban on new oil and gas leases, and more…

Week in Review

Week in Review

The Senate approves a $1.2 trillion infrastructure bill, the FDA allows a booster shot for vulnerable populations, and more…

Week in Review

Week in Review

The CDC extends eviction moratorium in some communities, the Labor Department rescinds Trump-era joint employer rule, and more…

Week in Review

Week in Review

The CDC updates its mask guidance for vaccinated individuals, President Biden requires federal employees to reveal their vaccination status, and more…

Week in Review

Week in Review

A federal court rules DACA unlawful, the White House issues guidance for federal climate and energy investments, and more…

Week in Review

Week in Review

President Biden signs an executive order to strengthen antitrust enforcement, FDA commissioner requests a federal investigation of a new Alzheimer’s drug, and more…

Week in Review

Week in Review

The FDA updates guidance on a new Alzheimer’s drug, the Chinese government increases scrutiny on Chinese companies that are publicly listed overseas, and more…

Week in Review

Week in Review

President Biden signs resolutions to overturn Trump-era rules, the Supreme Court upholds voting restrictions, and more…

Week in Review

Week in Review

President Biden releases gun violence prevention strategy, the Supreme Court strikes down the FHFA’s structure, and more…

Week in Review

Week in Review

The Supreme Court rejects a challenge to the Affordable Care Act, the Biden Administration releases its regulatory agenda, and more…